PH&T is an Italian pharmaceutical company engaged in research, development and production of generic drugs for specialist therapies and innovative medical devices, sold worldwide through licensees and distributors.

PH&T was founded in Milan in 1991 with the aim of selecting and developing niche products and selling them through firm commercial partnerships.
Our offer allows generic companies to complement their product portfolio with difficult-to-formulate, not top-selling pharmaceuticals.

Over 30 professionals form PH&T team, working together for the success of the company, from pipeline selection to dossier registration and finished product supply.

 


 

News PH&T  PH&T and Company Neda-e-Mahya Co., Iran, announce the official permission to import in Iran Calcitriol PH&T.

January 2010 : Iranian Company Neda-e-Mahya Co. has been granted by the Ministry of Health the official permission to import in Iran Calcitriol PH&T 1 mcg/1 ml injectable.

Read more...
 
News PH&T Exemestane PH&T proved bioequivalent to AromasinÒ (Pfizer)

December 2009   PH&T has developed Exemestane, the generic formulation of Aromasin® 25mg (Pfizer). 
Recently PH&T conducted a bioequivalence study to characterize the pharmacokinetic profile of its formulation (Exemestane PH&T 25mg sugar coated tablets) relative to that of reference formulation (Aromasin® 25mg sugar coated tablets).  

Read more...